Cardiovascular changes in chronic bronchopulmonary diseases in children.
Keywords:chronic bronchopulmonary diseases, cystic fibrosis, pulmonary hypertension
The article evaluates echocardiographic indicators of secondary PAH in 37 children with chronic bronchopulmonary disease. The study group included: 22 children with CF and 15 children with other chronic bronchopulmonary diseases. Echocardiographic monitoring in children with CF revealed an increase in PSAP values compared to children with chronic bronchopulmonary disease. TVI was detected in both groups, denoting a secondary impairment of the right heart in bronchopulmonary diseases. Varicose and cylindrical bronchiectasis were more common in children with CF presented as chronic bronchopulmonary disease with severe disability.
Cavus A., et al., Pediatric and Adolescent Pulmonary Hypertension: What Is the Risk of Undergoing Invasive Hemodynamic Testing? Journal of the American Heart Association, 2018.
Cordina, R. L., et al., State-of-the-Art Review: Echocardiography in Pulmonary Hypertension. Heart, Lung and Circulation, 2019.
Hansmann, G. Pulmonary Hypertension in Infants, Children, and Young Adults. Journal American College of Cardiology, 2017, 69(20), 2551–2569.
Li D., Wang, B., Wang, H., & Liu, Q. Prognostic significance of pulmonary hypertension in patients with cystic fibrosis. Medicine, 2018, 97(7), e970.8.
Nathan S. D., Barbera, J. A., Gaine, S. P., et al., Pulmonary hypertension in chronic lung disease and hypoxia. European Respiratory Journal, 2018.
Öcal S., Portakal, O., Öcal, et al. Factors associated with pulmonary hypertension and long-term survival in bronchiectasis subjects. Respiratory Medicine, 2016, 119, 109–114.
Rosenzweig E. B., Abman, S. H., Adatia, I., et al., Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. European Respiratory Journal, 2018, 1801916.
Wang L., Jiang, S., Shi, J., et al., Clinical characteristics of pulmonary hypertension in bronchiectasis. Frontiers of Medicine, 2016, 10(3), 336–344.
Wijeratne D.T., Lajkosz K., Brogly S.B. Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension. Circulation: Cardiovascular Quality and Outcomes, 2018, 11(2), e003973.
Copyright (c) 2022 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.